Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
Lingxi Jiang , Jiejie Qin , Yuting Dai , Shulin Zhao
Nature Medicine 1 -13
1
2024
Predictive models of recurrence from transcriptomic signatures of the tumor microenvironment and cell cycle in stage III colon cancer from PETACC-8 and IDEA France trials.
Claire Gallois , Marine SROUSSI , Thierry Andre , Sophie Mouillet-Richard
Journal of Clinical Oncology 41 ( 16_suppl) 3523 -3523
1
2023
BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma
Raëf Abdallah , Shulin Zhao , Simon Garinet , Katia Hormigos
Clinics and Research in Hepatology and Gastroenterology 46 ( 5) 101880 -101880
1
2022
Clinical application and potential usefulness of targeted next-generation sequencing on resected pancreatic ductal adenocarcinoma
Francesco Puleo , Rémy Nicolle , Yuna Blum , Jérôme Cros
Cancer Research 78 ( 13_Supplement) 4603 -4603
1
2018
Quel avenir pour l’ADN tumoral circulant? État des lieux et perspectives dans les cancers colorectaux, pulmonaires non à petites cellules et pancréatiques
Daniel Pietrasz , Nicolas Pécuchet , Elizabeth Fabre , Hélène Blons
Bulletin du Cancer 103 ( 1) 55 -65
1
2016
Detection of Microsatellite Instability in Colorectal Cancer Tissue and Plasma samples using a new Multiplex Droplet Digital PCR kit
Camille Evrard , Kariman Chaba , Justine Abdelli , Simon Garinet
medRxiv 2024.04. 12.24305349 -2024.04. 12.24305349
2024
Randomized phase II trial evaluating two sequential treatments in first line of metastatic pancreatic cancer: results of the PANOPTIMOX-PRODIGE 35 trial
Laetitia Dahan , Nicolas Williet , Karine Le Malicot , Jean-Marc Phelip
Journal of Clinical Oncology 39 ( 29) 3242 -3250
52
2021
Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer
Emeric Boisteau , Laetitia Dahan , Nicolas Williet , Karine Le Malicot
The Oncologist oyae079 -oyae079
2024
Prevalence of microsatellite instability in intraductal papillary mucinous neoplasms of the pancreas
Renato M Lupinacci , Anastasia Goloudina , Olivier Buhard , Jean-Baptiste Bachet
Gastroenterology 154 ( 4) 1061 -1065
100
2018
Stage II and stage III colon cancer: treatment advances and future directions
Benoît Rousseau , Benoist Chibaudel , Jean-Baptiste Bachet , Annette K Larsen
The Cancer Journal 16 ( 3) 202 -209
51
2010
New challenges in perioperative management of pancreatic cancer
Francesco Puleo , Raphaël Maréchal , Pieter Demetter , Maria-Antonietta Bali
World Journal of Gastroenterology 21 ( 8) 2281 -2293
65
2015
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials
Clémence Breton , Thomas Aparicio , Karine Le Malicot , Michel Ducreux
European Journal of Cancer 153 40 -50
4
2021
Abstract B014: Immuno-modulation of the tumor microenvironment of pancreatic adenocarcinoma following isotoxic high-dose stereotactic body radiotherapy (iHD-SBRT)
Christelle Bouchart , Oier Azurmendi Senar , Julie Navez , Laurine Verset
Cancer Research 84 ( 2_Supplement) B014 -B014
2024
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy
Christelle Bouchart , Oier Azurmendi Senar , Julie Navez , Laurine Verset
bioRxiv 2024.04. 30.591890 -2024.04. 30.591890
2024
Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study
Benoit Rousseau , Arezki K Boukerma , Julie Henriques , Romain Cohen
European Journal of Cancer 168 99 -107
6
2022
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF (IRIN) OX-based chemotherapy: A multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).
Lilian Schwarz , Jean-Baptiste Bachet , Aurelia Meurisse , Olivier Bouché
Journal of Clinical Oncology 40 ( 16_suppl) 4134 -4134
21
2022
FOLFIRINOX 对比吉西他滨治疗晚期胰腺癌
Thierry Conroy , Françoise Desseigne , Marc Ychou , Olivier Bouché
LIF drives neural remodeling in pancreatic cancer and offers a new candidate biomarker
Christian Bressy , Sophie Lac , Jérémy Nigri , Julie Leca
Cancer research 78 ( 4) 909 -921
102
2018
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy
Julien Taieb , Timothy Price , Loïck Vidot , Bénédicte Chevallier
BMC cancer 23 ( 1) 94 -94
5
2023
Impact of G-CSF prophylaxis on chemotherapy dose-intensity, link between dose-intensity and survival in patients with metastatic pancreatic adenocarcinoma
Clémence Canton , Olayidé Boussari , Mathieu Boulin , Karine Le Malicot
The Oncologist 27 ( 7) e571 -e579
4
2022